Logo
News Ababil
Explore
Stock Markets

Cerebras stock soars to $350 on debut, pushing valuation beyond $100 billion

By Arthur Sterling Published: May 16, 2026 2 MIN READ
Cerebras stock soars to $350 on debut, pushing valuation beyond $100 billion
2 Min Read
Share

Cerebras stock: valuation breakthrough

Cerebras stock erupted onto Nasdaq at $350 per share, nearly double its $185 IPO price, and vaulted the company past a $100 billion market cap in minutes. The debut made Cerebras one of the world’s most valuable semiconductor firms and vindicated a decade‑long bet on wafer‑scale AI chips. The company sold 30 million shares, raising ↑ $5.55 billion – the biggest U.S. tech IPO since Uber in 2019, according to Reuters. Revenue reached $510 million in 2025, while gross margin slipped ↓ 3.3% to 39% as the firm poured cash into cloud‑inference data centers.

Wafer‑scale engine fuels the surge

The third‑generation Wafer‑Scale Engine (WSE‑3) packs 4 trillion transistors, 900,000 compute cores and 44 GB of on‑chip memory – a physical size comparable to a dinner plate. Its bandwidth advantage translates into inference latency up to 15× faster than leading GPUs, a claim validated by independent benchmarks.

“We are filling more data halls with Cerebras systems to power the world’s fastest inference,” said Julie Choi, SVP and CMO, in an exclusive interview.

A cloud‑inference service launched in 2024 now accounts for $151.6 million of revenue, driven by a $20 billion contract with OpenAI and a strategic partnership with Amazon Web Services that will embed Cerebras chips in AWS data centers.


Intel provided by Arthur Sterling (Macroeconomics Editor).

Analysis By Arthur Sterling
Senior Intel Analyst & Contributing Editor. Focused on deep-tier geopolitical and market strategies.
Related Deep Dives

More from this Intel

Michael Burry dumps Alibaba ahead of massive Alibaba share sale

Michael Burry dumps Alibaba ahead of massive Alibaba share sale

Aug 23, 2026
Trump Stock Disclosure Reveals Over 1,000 Trades in June

Trump Stock Disclosure Reveals Over 1,000 Trades in June

Aug 23, 2026
News

AI Rout Triggers Broad Stock Sell‑off as DeepSeek Sparks Fear

Aug 22, 2026
Personalized mRNA Cancer Vaccine Propels Moderna and Merck Shares to New Heights

Personalized mRNA Cancer Vaccine Propels Moderna and Merck Shares to...

Aug 20, 2026
News

Unitree stock rockets 629% on debut, sparking robot‑maker frenzy

Aug 19, 2026
News

AI Rout Sends U.S. Stocks Tumbling as DeepSeek Sparks Panic

Aug 15, 2026

Join The Elite

Get the top 0.1% global intelligence and market insights delivered directly to your inbox before the masses.

We respect your privacy. No spam.